Global Health Limited has successfully concluded its postal ballot process, announcing comprehensive voting results on March 14, 2026. The company secured shareholder approval for all three resolutions presented during the remote e-voting process that concluded on March 13, 2026.

Postal Ballot Overview

The postal ballot was conducted under the supervision of scrutinizer Mr. Mukesh Kumar Agarwal from Mukesh Agarwal & Co., Practicing Company Secretaries. The remote e-voting process concluded on March 13, 2026 at 5:00 PM, with the scrutinizer submitting his report on March 14, 2026.

Resolution Results Summary

All three resolutions presented to shareholders achieved the required majority for approval. The voting demonstrated strong support from both promoter groups and public shareholders across institutional and non-institutional categories.

Resolution 1: Dr. Ravi Gupta Re-appointment

The special resolution for re-appointment of Dr. Ravi Gupta (DIN: 00023487) as Independent Director received overwhelming support:

Resolution 2: Mr. Rajan Bharti Mittal Re-appointment

The special resolution for re-appointment of Mr. Rajan Bharti Mittal (DIN: 00028016) as Independent Director also secured strong approval:

Resolution 3: Ms. Shonan Purie Trehan Appointment

The ordinary resolution for appointment of Ms. Shonan Purie Trehan (DIN: 07078955) as Non-Executive Non-Independent Director achieved the highest approval rate:

Regulatory Compliance and Communication

The company has communicated the postal ballot results to both BSE Limited and National Stock Exchange of India Limited through official correspondence dated March 14, 2026. Company Secretary Rahul Ranjan submitted the voting results in compliance with Regulation 44 and 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The voting results and consolidated scrutinizer's report have been uploaded on the company's investor relations website and the National Securities Depository Limited's e-voting platform. The postal ballot notice was dispatched electronically to all eligible shareholders on February 10, 2026, with advertisements published in Financial Express and Jansatta newspapers on February 11, 2026.

Voting Process Details

Key voting statistics showed strong participation with 89.77% of outstanding shares participating in the voting process across all three resolutions. The votes were unblocked on March 13, 2026 at 5:23 PM in the presence of two independent witnesses. The company fulfilled all regulatory requirements ensuring complete transparency in the postal ballot process.

Invesco Mutual Fund has reported a substantial acquisition disclosure for Global Health Limited under SEBI Regulation 29(1), with the fund house crossing the 5% threshold in the healthcare company's equity shares. The disclosure, dated February 23, 2026, indicates that Invesco's aggregate holding reached 5.0273% of Global Health Limited's paid-up share capital as of the close of business hours on February 20, 2026.

Acquisition Details

The mutual fund acquired 10,01,873 shares through open market transactions, representing 0.3727% of the total share capital. This acquisition increased Invesco's total holding from 1,25,11,138 shares to 1,35,13,011 shares.

Participating Schemes

The investment was made across 14 different Invesco schemes, demonstrating diversified participation from the fund house's portfolio:

• Invesco India Business Cycle Fund
• Invesco India Aggressive Hybrid Fund
• Invesco India ESG Integration Strategy Fund
• Invesco India Flexi Cap Fund
• Invesco India Focused Fund
• Invesco India Consumption Fund
• Invesco India Smallcap Fund
• Invesco India Largecap Fund
• Invesco India Contra Fund
• Invesco India Large & Mid Cap Fund
• Invesco India Infrastructure Fund
• Invesco India Midcap Fund
• Invesco India Multicap Fund
• Invesco India ELSS Tax Saver Fund

Company Information

Global Health Limited maintains its equity share capital at Rs. 53,75,80,764, comprising 26,87,90,382 equity shares of Re. 2 each. The company's shares are listed on both BSE Limited and National Stock Exchange of India Limited.

Regulatory Compliance

The disclosure was made in accordance with Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. Hardik Mehta, Chief Risk Officer at Invesco Asset Management (India) Private Limited, signed the disclosure document. The notification confirms that Invesco does not belong to the promoter or promoter group of Global Health Limited.

The disclosure was simultaneously communicated to Global Health Limited's management and the listing departments of both BSE Limited and National Stock Exchange of India Limited, ensuring full regulatory compliance and transparency in the substantial acquisition process.